Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis.
Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.
SourceJournal of tropical pediatrics 59:6 2013 Dec pg 507-8
Vasculitis, Leukocytoclastic, Cutaneous
Pub Type(s)Case Reports